186 related articles for article (PubMed ID: 30303650)
21. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J
Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
[TBL] [Abstract][Full Text] [Related]
22. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
Gan L; Zhou Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152
[TBL] [Abstract][Full Text] [Related]
23. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
[TBL] [Abstract][Full Text] [Related]
25. [Risk factors for anemia in the early stages of chronic kidney disease].
Milovanov YS; Kozlovskaya LV; Milovanova LY; Markina MM; Kozlov VV; Taranova MV; Fomin VV
Ter Arkh; 2017; 89(6):41-47. PubMed ID: 28745688
[TBL] [Abstract][Full Text] [Related]
26. Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study.
Kim HJ; Lee J; Chae DW; Lee KB; Sung SA; Yoo TH; Han SH; Ahn C; Oh KH
BMC Nephrol; 2019 Apr; 20(1):119. PubMed ID: 30943913
[TBL] [Abstract][Full Text] [Related]
27. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
Scholze A; Liu Y; Pedersen L; Xia S; Roth HJ; Hocher B; Rasmussen LM; Tepel M
J Clin Endocrinol Metab; 2014 May; 99(5):E855-61. PubMed ID: 24606097
[TBL] [Abstract][Full Text] [Related]
28. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
Kacso IM; Bondor CI; Kacso G
Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
[TBL] [Abstract][Full Text] [Related]
29. In chronic kidney disease, serum α-Klotho is related to serum bicarbonate and proteinuria.
Hage V; Pelletier S; Dubourg L; Drai J; Cuerq C; Lemoine S; Hadj-Aissa A; Laville M; Fouque D
J Ren Nutr; 2014 Nov; 24(6):390-4. PubMed ID: 25193108
[TBL] [Abstract][Full Text] [Related]
30. Serum klotho levels in acute kidney injury
.
Seibert E; Radler D; Ulrich C; Hanika S; Fiedler R; Girndt M
Clin Nephrol; 2017 Apr; 87 (2017)(4):173-179. PubMed ID: 28157067
[TBL] [Abstract][Full Text] [Related]
31. Proteinuria as a risk marker for the progression of chronic kidney disease in patients on predialysis care and the role of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment.
de Goeij MC; Liem M; de Jager DJ; Voormolen N; Sijpkens YW; Rotmans JI; Boeschoten EW; Dekker FW; Grootendorst DC; Halbesma N;
Nephron Clin Pract; 2012; 121(1-2):c73-82. PubMed ID: 23128440
[TBL] [Abstract][Full Text] [Related]
32. Influence of exogenous growth hormone administration on circulating concentrations of α-klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study.
Adema AY; de Roij van Zuijdewijn CLM; Hoenderop JG; de Borst MH; Ter Wee PM; Heijboer AC; Vervloet MG;
BMC Nephrol; 2018 Nov; 19(1):327. PubMed ID: 30442108
[TBL] [Abstract][Full Text] [Related]
33. Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.
Ozeki M; Fujita S; Kizawa S; Morita H; Sohmiya K; Hoshiga M; Ishizaka N
BMC Nephrol; 2014 Sep; 15():147. PubMed ID: 25200959
[TBL] [Abstract][Full Text] [Related]
34. Serum tryptase concentration and progression to end-stage renal disease.
Jesky MD; Stringer SJ; Fenton A; Ng KP; Yadav P; Ndumbo M; McCann K; Plant T; Dasgupta I; Harding SJ; Drayson MT; Redegeld F; Ferro CJ; Cockwell P
Eur J Clin Invest; 2016 May; 46(5):460-74. PubMed ID: 26999448
[TBL] [Abstract][Full Text] [Related]
35. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
[TBL] [Abstract][Full Text] [Related]
36. Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease.
Soares AE; Maes M; Godeny P; Matsumoto AK; Barbosa DS; da Silva TAF; Souza FHMO; Delfino VDA
Life Sci; 2017 Dec; 191():175-179. PubMed ID: 29079468
[TBL] [Abstract][Full Text] [Related]
37. Circulating α-Klotho is Related to Plasma Aldosterone and Its Follow-Up Change Predicts CKD Progression.
Qian J; Zhong J; Yan M; Cheng P; Shi H; Hao C; Gu Y; Lai L
Kidney Blood Press Res; 2018; 43(3):836-846. PubMed ID: 29843135
[TBL] [Abstract][Full Text] [Related]
38.
Pei Y; Miu M; Mao X; Chen W; Zhu J
Int J Clin Pract; 2023; 2023():8244545. PubMed ID: 38187354
[TBL] [Abstract][Full Text] [Related]
39. Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease.
Yi HJ; Lee JB; Lee KP; Oh YI; Song KH; Seo KW
BMC Vet Res; 2020 Jul; 16(1):246. PubMed ID: 32677951
[TBL] [Abstract][Full Text] [Related]
40. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
